StonvexLoading…
StonvexStonvexStonvexCore line items from DLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-27 | Q4 2025 2025-12-26 | Annual 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $742.34M | $346.71M | $1.35B | $1.04B |
Operating Income | $175.11M | $62.16M | $264.96M | $235.28M |
Net Income | $148.24M | $53.33M | $255.02M | $205.69M |
EPS (Diluted) | $1.54 | $0.55 | $2.62 | $2.11 |
Total Assets | $3.25B | $3.19B | $3.23B | $3.20B |
Total Liabilities | $622.36M | $589.25M | $595.81M | $581.75M |
Cash & Equivalents | $594.28M | $643.85M | $701.89M | $698.57M |
Free Cash Flow OCF − CapEx | $133.62M | $50.17M | $435.85M | $329.26M |
Shares Outstanding | 96.27M | 96.52M | 97.48M | 97.54M |